SAN FRANCISCO (GenomeWeb) – Startup Orbit Genomics plans to develop next-generation sequencing-based assays that analyze microsatellite sequences to diagnose cancer and other diseases.
The Boulder, Colorado-based firm, which was founded last year by CSO Harold Garner, CEO Dede Willis, and others, leverages research done by Garner on microsatellites as well as publicly available genomic databases, like the Cancer Genome Atlas to discover and validate microsatellite markers of disease.